Deutsche Bank analyst Kyle White raised the firm’s price target on AptarGroup to $134 from $130 and keeps a Buy rating on the shares. The company’s pharma strength continues while its potential cost savings are being overlooked, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATR:
